Stock Falling

Discussion in 'Radius Health' started by anonymous, Jul 25, 2018 at 7:51 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    BUY BUY BUY !!!
     

  2. anonymous

    anonymous Guest

    Expect a bump in the price before the final death spiral.
    Earnings were leaked.
     
  3. anonymous

    anonymous Guest

    DOOM AND GLOOM!
     
  4. anonymous

    anonymous Guest

    Another 52 week low. Next up, market cap drops below $900M...
     
  5. anonymous

    anonymous Guest

    Tymlos will be sold to some company that will hire a contract sales force to promote the product and Radius will be just another company that didn’t make it by this time next year, bank on it!$
     
  6. anonymous

    anonymous Guest

    Wow- actually closed below 20.. Jesper's been here about a year and how much has the stock dropped? Docs are paying attention- expect confidence and then sales to start to decline.
     
  7. anonymous

    anonymous Guest

    BYE BYE BYE !!!
     
  8. anonymous

    anonymous Guest

    $19.99 Sounds like a Wal-Mart blue light special.
     
  9. anonymous

    anonymous Guest

    So tonight I’m gonna party like it’s $19.99!!
     
  10. anonymous

    anonymous Guest

    Looks like someone actually got it right with the “in the teens by October” comment above.
     
  11. anonymous

    anonymous Guest

    In the teens in August. All I can say is you better dust off that resume and start contacting your recruiters. Don't be blind to this situation.
     
  12. anonymous

    anonymous Guest

    It is a good product. Problem is the company.
     
  13. anonymous

    anonymous Guest

    Me too. I’d party harder if we could get bought.
     
  14. anonymous

    anonymous Guest

    It’s a me too... and being that the company sucks really bad, makes us not even want to push it. Misery. My manager is a mess. Needs psychological help, but is apparently a psychologist. Hmmm....
     
  15. anonymous

    anonymous Guest

    Potential Investor here.. so you folks on the inside.. is there any upside here? Is there any rumbling of a buyout internally? How is JH regarded inside? Seems okay on calls and such but I know this is only the tip of the iceberg. Thanks!
     
  16. anonymous

    anonymous Guest

    You're actually coming here for information? Well JH is a tool (a pure pawn for the board). Wall Street just hasn't held his feet to the fire yet. Every company that has looked at this company has passed (including a very desperste Shire). A buyout is highly unlikely at this point in the game. You are truly a gambler if you're looking to invest here.
     
  17. anonymous

    anonymous Guest

    Thanks for the info and good to know. I haven’t invested yet, doing my HW first but with an approved drug and 2-3 others in the pipeline I would think it is priced as a steal right now? Company tanks, there is still IP in the drug.. I would appreciare any additional insights. Thanks
     
  18. anonymous

    anonymous Guest

    You're ROI will be if the cancer products pan out. Tymlos is getting ready to have generic market intrusion, so it's not a drug that potential buyers are interested in.
     
  19. anonymous

    anonymous Guest

    What's up with manufacturing - everything alright ?
     
  20. anonymous

    anonymous Guest

    Nothing is "alright" here.